Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1518 |
Olmesartan Medoxomil
奥美沙坦酯,CS 866,Benicar |
RAAS | Endocrinology/Hormones |
Olmesartan Medoxomil (Benicar) 是血管紧张素 (angiotensin AT1) 受体选择性抑制剂(IC50:66.2 μM)。 | |||
T36006 |
Olmesartan medoxomil impurity C
|
||
Olmesartan medoxomil impurity C is an Olmesartan medoxomil impurity. Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM. [1]. Senda A, et al. Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8. Biol Pharm Bull. 2015;38(12):1975-9. [2]. Shah S, et al. Simultaneous Quantitative Analysis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique. J Young Phar... | |||
T74016 |
Trityl olmesartan medoxomil impurity III
|
||
Trityl olmesartan medoxomil impurity II为Trityl olmesartan medoxomil的杂质,后者是Olmesartan medoxomil的中间体。 | |||
T5964 |
Olmesartan
CS 088,奥美沙坦,RNH 6270 |
RAAS | Endocrinology/Hormones |
Olmesartan (RNH 6270) 是一种血管紧张素 II 受体 (AT1R) 拮抗剂,常用于研究高血压。 | |||
T70923 | Olmesartan methyl ester | ||
Olmesartan methyl ester is an intermediate in the synthesis of Olmesartan medoxomil. Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor antagonist. | |||
T35642 | Tritylolmesartan Medoxomil | ||
Tritylolmesartan medoxomil is an intermediate in the synthesis of olmesartan medoxomil , a prodrug form of the angiotensin II receptor 1 (AT1) antagonist olmesartan .1 1.Hanumantha Rao, B., Subramanyeswara Rao, I.V., Ravi Kanth, V., et al.A competent and commercially viable process for the synthesis of the anti-hypertensive drug olmesartan medoxomilSci. Pharm.83(3)465-478(2015) |